Insider Selling: NEXGEL, Inc. (NASDAQ:NXGL) CEO Sells $12,640.00 in Stock

NEXGEL, Inc. (NASDAQ:NXGL) CEO Adam R. Levy sold 4,000 shares of the firm’s stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $3.16, for a total value of $12,640.00. Following the completion of the sale, the chief executive officer now owns 374,284 shares of the company’s stock, valued at approximately $1,182,737.44. This trade represents a 1.06 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

NEXGEL Price Performance

NEXGEL stock opened at $2.95 on Friday. The business’s 50-day simple moving average is $3.48 and its 200 day simple moving average is $3.25. The stock has a market cap of $20.03 million, a price-to-earnings ratio of -5.09 and a beta of 0.62. NEXGEL, Inc. has a 12-month low of $1.84 and a 12-month high of $5.10. The company has a quick ratio of 0.93, a current ratio of 1.51 and a debt-to-equity ratio of 0.19.

Hedge Funds Weigh In On NEXGEL

Hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC bought a new position in NEXGEL in the fourth quarter valued at about $48,000. IFP Advisors Inc bought a new position in NEXGEL in the fourth quarter valued at about $49,000. Two Sigma Securities LLC bought a new position in NEXGEL in the fourth quarter valued at about $54,000. Northeast Financial Group Inc. boosted its holdings in NEXGEL by 168.8% in the third quarter. Northeast Financial Group Inc. now owns 31,848 shares of the company’s stock valued at $82,000 after acquiring an additional 20,000 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in NEXGEL by 5.8% in the fourth quarter. Geode Capital Management LLC now owns 60,142 shares of the company’s stock valued at $268,000 after acquiring an additional 3,302 shares during the last quarter. Institutional investors own 2.21% of the company’s stock.

About NEXGEL

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.